CORDIS
EU research results

CORDIS

English EN

Predicting Effective Adaptation to Breast Cancer to Help Women to BOUNCE Back

Objective

Coping with breast cancer more and more becomes a major socio-economic challenge not least due to its constantly increasing incidence in the developing world. There is a growing need for novel strategies to improve understanding and capacity to predict resilience of women to the variety of stressful experiences and practical challenges related to breast cancer. This is a necessary step toward efficient recovery through personalized interventions. BOUNCE will bring together modeling, medical, and social sciences experts to advance current knowledge on the dynamic nature of resilience as it relates to efficient recovery from breast cancer. BOUNCE will take into consideration clinical, cancer-related biological, lifestyle, and psychosocial parameters in order to predict individual resilience trajectories throughout the cancer continuum and eventually increase resilience in breast cancer survivors and help them remain in the workforce and enjoy a better quality of life.
BOUNCE will deliver a unified clinical model of modifiable factors associated with optimal disease outcomes and will deploy a prospective multi-center clinical pilot at four major oncology centers (in Italy, Finland, Israel and Portugal), where a total of 660 women will be recruited in order to assess its clinical validity against crucial patient outcomes (illness progression, wellbeing, and functionality). The advanced computational tools to be employed will validate indices of patients’ capacity to bounce back during the highly stressful treatment and recovery period following diagnosis of breast cancer. The overreaching goal of BOUNCE is to incorporate elements of a dynamic, predictive model of patient outcomes in building a decision-support system used in routine clinical practice to provide physicians and other health professionals with concrete, personalized recommendations regarding optimal psychosocial support strategies.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

HELSINGIN JA UUDENMAAN SAIRAANHOITOPIIRIN KUNTAYHTYMÄ

Address

Stenbackinkatu 9
00029 Helsinki

Finland

Activity type

Research Organisations

EU Contribution

€ 795 625

Participants (8)

Sort alphabetically

Sort by EU Contribution

Expand all

IDRYMA TECHNOLOGIAS KAI EREVNAS

Greece

EU Contribution

€ 726 875

ISTITUTO EUROPEO DI ONCOLOGIA SRL

Italy

EU Contribution

€ 375 600

INSTITUTE OF COMMUNICATION AND COMPUTER SYSTEMS

Greece

EU Contribution

€ 457 500

NHG CONSULTING OY

Finland

EU Contribution

€ 747 435

THE HEBREW UNIVERSITY OF JERUSALEM

Israel

EU Contribution

€ 515 000

SINGULARLOGIC ANONYMI ETAIREIA PLIROFORIAKON SYSTIMATON KAI EFARMOGON PLIROFORIKIS

Greece

EU Contribution

€ 448 125

FUNDACAO D. ANNA SOMMER CHAMPALIMAUD E DR. CARLOS MONTEZ CHAMPALIMAUD

Portugal

EU Contribution

€ 497 000

NOONA HEALTHCARE OY

Finland

EU Contribution

€ 436 250

Project information

Grant agreement ID: 777167

Status

Ongoing project

  • Start date

    1 November 2017

  • End date

    31 October 2021

Funded under:

H2020-EU.3.1.5.

  • Overall budget:

    € 4 999 410

  • EU contribution

    € 4 999 410

Coordinated by:

HELSINGIN JA UUDENMAAN SAIRAANHOITOPIIRIN KUNTAYHTYMÄ

Finland